1. Home
  2. IDYA vs PBH Comparison

IDYA vs PBH Comparison

Compare IDYA & PBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IDEAYA Biosciences Inc.

IDYA

IDEAYA Biosciences Inc.

HOLD

Current Price

$32.46

Market Cap

2.9B

Sector

Health Care

ML Signal

HOLD

Logo Prestige Consumer Healthcare Inc.

PBH

Prestige Consumer Healthcare Inc.

HOLD

Current Price

$57.60

Market Cap

2.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IDYA
PBH
Founded
2015
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
2.5B
IPO Year
2019
2004

Fundamental Metrics

Financial Performance
Metric
IDYA
PBH
Price
$32.46
$57.60
Analyst Decision
Strong Buy
Buy
Analyst Count
16
3
Target Price
$52.86
$75.33
AVG Volume (30 Days)
1.5M
515.5K
Earning Date
05-05-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
61.90
2.88
EPS
N/A
2.78
Revenue
$218,710,000.00
$975,777,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$199.11
$4.31
P/E Ratio
N/A
$20.67
Revenue Growth
3024.43
36.77
52 Week Low
$16.81
$51.24
52 Week High
$39.28
$88.00

Technical Indicators

Market Signals
Indicator
IDYA
PBH
Relative Strength Index (RSI) 51.41 43.21
Support Level $29.29 $57.25
Resistance Level $34.76 $63.56
Average True Range (ATR) 2.09 2.11
MACD 0.12 0.32
Stochastic Oscillator 30.74 67.41

Price Performance

Historical Comparison
IDYA
PBH

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275 (Werner Helicase), IDE161 (PARG), and IDE705 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

About PBH Prestige Consumer Healthcare Inc.

Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.

Share on Social Networks: